#United States #Milwaukee #Lohman Technologies #Salvo Health #HomECG+

Enhancing Remote Gastrointestinal Care: A Strategic Partnership

Lohman Technologies has announced a significant expansion of its strategic partnership with Salvo Health, emphasizing a collaborative effort aimed at enhancing remote care solutions for patients with gastrointestinal (GI) conditions. This advancement follows a successful initial collaboration that started in 2024. The previous integration allowed for the use of the HomECG+ medical-grade home ECG monitoring device by Salvo Health, which specializes in virtual care for GI and metabolic disorders.

With a focus on improving the healthcare experience for patients suffering from conditions such as Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD), the renewed partnership facilitates the deployment of Lohman’s devices to a broader network of GI clinics. Notably, this expansion will reach six additional states in 2026, encompassing Ohio, Virginia, Maryland, Colorado, Massachusetts, and Washington. This marks a substantial increase from their existing operations, which already include Georgia, Florida, Michigan, and New York.

The Power of Innovative Technology

Lohman Technologies is recognized for its groundbreaking HomECG+ device, which stands out for its accuracy and ease of use, providing critical health insights without requiring smartphone connectivity or Wi-Fi. Jason Dvorak, the President of Lohman Technologies, emphasized that this partnership grants Salvo a competitive edge, as they leverage the HomECG+ technology as part of their wraparound care model. Through this integration, Salvo's healthcare teams can monitor heart rate variability (HRV) as an essential metric to assess patient progress, ultimately aiming to improve overall health outcomes.

The focus is to shift patient responses from high-stress states, described as 'fight or flight,' to calmer states of 'rest and digest.' This holistic approach is particularly beneficial in managing the interplay between stress and its impact on GI and cardiometabolic conditions.

Driving Better Health Outcomes

Jeff Glueck, Co-Founder and CEO of Salvo Health, highlighted how this partnership significantly bolsters patient care. Patients will experience a simplified and user-friendly interface with the HomECG+ device, allowing for straightforward and effective management of their conditions. The immediate feedback helps patients track their health and engage with their care teams more effectively, reinforcing the commitment to providing high-quality virtual care within local practices.

Salvo's model combines the advantages of a mobile application, dedicated support teams, and thorough coordination with local physicians, ensuring patients receive comprehensive and continuous care.

Moreover, the early data stemming from this joint initiative indicates a promising uptick in patient engagement and the clinical effectiveness of using Lohman's technology. Patients have expressed satisfaction with the ease of performing HRV tests—no smartphone or Wi-Fi equipment necessary—and the near-real-time transmission of their health data to their healthcare teams.

Commitment to Continuous Improvement

As Lohman Technologies expands its collaborations and explores new innovative solutions, the company remains focused on further improving the continuum of care for cardiovascular monitoring and managing chronic cardiac conditions. Lohman’s commitment to enhancing patient care through technology aligns seamlessly with Salvo’s goal of delivering consistent and coordinated care. This partnership is set to redefine standards in hybrid virtual healthcare, particularly for those grappling with complex GI and metabolic illnesses.

In summary, this strategic partnership signifies a proactive step towards better healthcare delivery models, accurately reflecting the evolving landscape of remote patient monitoring. As the health industry continues to innovate, initiatives like those between Lohman Technologies and Salvo Health showcase the potential for technology to revolutionize patient care, ultimately leading to improved health outcomes across populations.

About Lohman Technologies and Salvo Health

Lohman Technologies is a pioneering company recognized for its innovative health monitoring solutions. Their flagship product, HomECG+, has been instrumental in redefining cardiac care accessibility.

Salvo Health focuses on providing integrated care strategies for managing GI and metabolic conditions, ensuring each patient's journey is supported by a holistic and interdisciplinary approach to healthcare.

For more information on their initiatives, please visit Lohman Technologies and Salvo Health.